Efficacy and safety of allogeneic umbilical cord blood mononuclear cells therapy in children with autism spectrum disorder and immune dysregulation: a single-center, double-blinded, randomized, placebo-controlled trial.
Zhang Z et al. · 2026
NCBI PubMed Central · Papers · License: Open Access · 2026